Alexander White
Family Medicine · Daytona Beach, FLNPI 1285687459
Payments from drug & device makers
Across 1,752 payments — averaging $39,789 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$32.9M
- Janssen Research & Development, LLC$10.2M
- Eisai Inc.$7.3M
- Genentech, Inc.$5.5M
- Pfizer$3.7M
- Novartis$3.1M
- plus $7.2M from 29 others
Across 29 payments — averaging $10,474 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$274K
- Avid Radiopharmaceuticals, Inc.$20K
- Pfizer$8K
- GSK$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 105 | $32,862,216 |
| Janssen Research & Development, LLC | 290 | $10,157,298 |
| Eisai Inc. | 190 | $7,315,872 |
| Genentech, Inc. | 183 | $5,465,467 |
| Pfizer | 240 | $3,669,370 |
| Novartis | 42 | $3,070,801 |
| Biogen | 8 | $1,591,394 |
| Amgen | 6 | $1,201,927 |
| Astrazeneca UK Limited | 7 | $770,235 |
| Regeneron | 68 | $626,375 |
| E.r. Squibb & Sons, L.L.C. | 15 | $493,732 |
| GSK | 70 | $367,364 |
| Applied Therapeutics, Inc. | 59 | $339,044 |
| AstraZeneca | 9 | $286,483 |
| Kowa Research Institute, Inc. | 14 | $214,628 |
| GRT US Holding, Inc. | 52 | $206,056 |
| UCB SA | 8 | $174,995 |
| AbbVie | 121 | $159,862 |
| Johnson & Johnson | 26 | $157,454 |
| Chiesi USA, Inc. | 115 | $134,718 |
| Astrazeneca AB | 4 | $121,287 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $54,054 |
| Novo Nordisk AS | 12 | $47,661 |
| Sanofi Pasteur Inc. | 4 | $39,500 |
| Cipla USA Inc. | 28 | $37,872 |
| Corcept Therapeutics | 19 | $37,057 |
| Pacira Therapeutics, Inc. | 2 | $36,880 |
| Madrigal Pharmaceuticals | 3 | $24,919 |
| Boehringer Ingelheim International GmbH | 15 | $23,715 |
| Lexicon Pharmaceuticals, Inc. | 5 | $16,794 |
| Shionogi Inc | 3 | $1,941 |
| Mylan Specialty L.p. | 1 | $1,500 |
| Merck | 8 | $1,077 |
| Genentech USA, Inc. | 3 | $334 |
| Lilly USA, LLC | 1 | $34 |
How this compares
$69,709,914 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Daytona Beach
- Hugh ColemanDaytona Beach$115.5M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
- Craig CurtisKissimmee$14.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.